Pages that link to "Q40876216"

The following pages link to Relationship between atrial fibrillation and typical atrial flutter in humans: activation sequence changes during spontaneous conversion (Q40876216):

Displaying 43 items.

• QUest for the Arrhythmogenic Substrate of Atrial fibRillation in Patients Undergoing Cardiac Surgery (QUASAR Study): Rationale and Design (Q27343062) (← links)
• Atrial flutter: contemporary electrophysiology and catheter ablation (Q33543826) (← links)
• The role of nonpharmacologic therapies for the treatment of atrial fibrillation (Q33598003) (← links)
• What is the relationship of atrial flutter and fibrillation? (Q33611435) (← links)
• Novel catheter technology for ablative cure of atrial fibrillation (Q33789892) (← links)
• Healthcare utilization and clinical outcomes after catheter ablation of atrial flutter (Q33830174) (← links)
• Management of atrial flutter (Q34011195) (← links)
• Insights gained into form and function of the posterior left atrium (Q35161003) (← links)
• Hybrid therapy in the management of atrial fibrillation. (Q35168786) (← links)
• Inter-relationships between atrial flutter and atrial fibrillation (Q35197747) (← links)
• The muscular network of the sheep right atrium and frequency-dependent breakdown of wave propagation (Q35889881) (← links)
• Optimization of pacing algorithms to prevent and treat supraventricular tachyarrhythmias (Q36684059) (← links)
• Critical mass hypothesis revisited: role of dynamical wave stability in spontaneous termination of cardiac fibrillation (Q36816861) (← links)
• Hybrid pharmacological and ablative therapy for the management of symptomatic atrial fibrillation (Q36817197) (← links)
• Typical atrial flutter can effectively be treated using single one-minute cryoapplications: results from a repeat electrophysiological study (Q37352103) (← links)
• Management of atrial fibrillation in patients with congenital heart defects (Q38286183) (← links)
• Management of atrial fibrillation in bradyarrhythmias (Q38381414) (← links)
• Atrial Fibrillation after Radiofrequency Ablation of Type I Atrial Flutter (Q38790408) (← links)
• Incidence and clinical predictors of subsequent atrial fibrillation requiring additional ablation after cavotricuspid isthmus ablation for typical atrial flutter (Q40277278) (← links)
• Differences in organization between acute and chronic atrial fibrillation in dogs (Q40747916) (← links)
• Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation (Q43602408) (← links)
• Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: insights from a study using a new implantable device (Q43703656) (← links)
• Which is the best approach for ablation of long-standing persistent atrial fibrillation? (Q43753124) (← links)
• Conduction properties of the crista terminalis in patients with atrial flutter due to amiodarone therapy for atrial fibrillation (Q44692919) (← links)
• Spontaneous transition from atrial fibrillation to typical atrial flutter during catheter ablation of the pulmonary vein (Q44888511) (← links)
• Atrial flutter ablation in inducible patients during pulmonary vein atrum isolation: a randomized comparison (Q45760652) (← links)
• Mechanism of conversion of atypical right atrial flutter to atrial fibrillation. (Q46010561) (← links)
• Progress toward a catheter ablative cure of atrial fibrillation (Q46145315) (← links)
• Electromechanical effects of 1,25-dihydroxyvitamin d with antiatrial fibrillation activities (Q48410174) (← links)
• Pharmacological and ablative hybrid therapy of atrial fibrillation. Long-term effect on quality of life and arrhythmia-related symptoms. (Q53281778) (← links)
• Dynamic alterations in right atrial activation during atrial fibrillation (Q73161395) (← links)
• Atrial Flutter (Q73236653) (← links)
• Electrocardiographic and Electrophysiological Characteristics of Atrial Fibrillation Organized Into Atrial Flutter by Oral Administration of Class I Antiarrhythmic Agents (Q73278230) (← links)
• Occurrence of atrial fibrillation after flutter ablation: the significance of intra-atrial conduction and atrial vulnerability (Q73867517) (← links)
• Is atrial flutter a risk factor for stroke? (Q74438996) (← links)
• The linear ablation of atrial fibrillation in the right atrium: can the isthmus ablation improve its efficacy? (Q74558861) (← links)
• Radiofrequency catheter ablation of atrial flutter and atrial fibrillation (Q74835415) (← links)
• Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation (Q78050780) (← links)
• Early versus late atrial fibrillation after atrial flutter ablation (Q78050785) (← links)
• Electrophysiologic characteristics of the spontaneous onset and termination of atrial fibrillation (Q78569601) (← links)
• Recurrent atrial flutter and atrial fibrillation after catheter ablation of the cavotricuspid isthmus: a very long-term follow-up of 333 patients (Q78740741) (← links)
• Incidence of atrial fibrillation in heart transplant patients: long-term follow-up (Q80097740) (← links)
• Right Atrial Remodeling is More Advanced in Patients with Atrial Flutter Than with Atrial Fibrillation (Q84184438) (← links)